Martin D. Auster

Marty serves as Chief Financial Officer. Prior to joining Ventyx, he served as Managing Director, Biotechnology Analyst at Credit Suisse. Prior to Credit Suisse, he was a senior biotechnology analyst at UBS Securities. Prior to that, he served as an executive at Ascendis Pharma and United Therapeutics. Earlier in his career, he held positions in the investment banking industry, including as a Senior Biotechnology Analyst at Wachovia Securities and a Senior Analyst/Healthcare-focused Portfolio Manager at GLG Partners. He received a B.A. from the University of Michigan and an M.D. from the University of Texas Medical Branch.